Propanc Biopharma, Inc.
PPCBNasdaqCIK 1517681HealthcareFiscal year ends Jun 30
Reports and events: 233 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-05-1606:05 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001493152-24-020101 |
| 2024-05-1516:38 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001493152-24-019940 |
| 2024-04-2212:12 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-24-015494 |
| 2024-04-1016:20 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-014213 |
| 2024-03-1115:15 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-24-009536 |
| 2024-02-2014:39 ET | 10-Q | Quarterly reportPeriod 2023-12-31 | 0001493152-24-007191 |
| 2023-12-1515:57 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-23-045035 |
| 2023-12-0716:18 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-23-044022 |
| 2023-11-1415:03 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001493152-23-040980 |
| 2023-10-3016:05 ET | 8-K | 8.01 Other events | 0001493152-23-038668 |
| 2023-10-2616:42 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-23-038400 |
| 2023-10-1720:56 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-23-037423 |
| 2023-10-1006:07 ET | S-1/A | Registration statement, amended | 0001493152-23-036599 |
| 2023-10-0617:26 ET | S-1/A | Registration statement, amended | 0001493152-23-036563 |
| 2023-09-2816:16 ET | 10-K | Annual reportPeriod 2023-06-30 | 0001493152-23-034632 |
| 2023-08-2906:04 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-23-030413 |
| 2023-08-2117:25 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-23-029723 |
| 2023-08-1117:20 ET | S-1 | Registration statement | 0001493152-23-027886 |
| 2023-08-0816:06 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-23-027171 |
| 2023-07-2616:05 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-23-025571 |
| 2023-07-1218:35 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-23-024277 |
| 2023-05-1516:11 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001493152-23-017346 |
| 2023-05-1516:06 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 2.04 Item not in the standard list; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-23-017322 |
| 2023-05-0517:03 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-23-015643 |
| 2023-03-1716:20 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-23-008082 |
| 2023-02-2211:19 ET | 8-K | 8.01 Other events | 0001493152-23-005757 |
| 2023-02-2117:23 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-23-005702 |
| 2023-02-1017:53 ET | 10-Q | Quarterly reportPeriod 2022-12-31 | 0001493152-23-004150 |
| 2022-11-1416:34 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001493152-22-032116 |
| 2022-11-0117:11 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-22-030113 |
| 2022-10-1212:47 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-22-028230 |
| 2022-09-2816:16 ET | 10-K | Annual reportPeriod 2022-06-30 | 0001493152-22-027033 |
| 2022-09-2711:43 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-22-026871 |
| 2022-08-1814:37 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-22-023445 |
| 2022-07-1106:10 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-22-018970 |
| 2022-07-0716:30 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-22-018808 |
| 2022-05-1812:29 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-22-014290 |
| 2022-05-1611:24 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001493152-22-013577 |
| 2022-04-1814:19 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-22-010217 |
| 2022-04-0114:59 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-22-008771 |
| 2022-03-1013:31 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-22-006482 |
| 2022-02-1413:14 ET | 10-Q | Quarterly reportPeriod 2021-12-31 | 0001493152-22-004382 |
| 2022-02-1011:17 ET | S-1/A | Registration statement, amended | 0001493152-22-003713 |
| 2022-02-0316:20 ET | S-1 | Registration statement | 0001493152-22-003104 |
| 2022-01-1006:15 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-22-000746 |
| 2021-12-1312:46 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-21-031218 |
| 2021-12-0716:37 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-21-030703 |
| 2021-12-0113:07 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-21-030167 |
| 2021-11-1216:56 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001493152-21-028221 |
| 2021-10-2708:27 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-21-026408 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 17:01 ET. Listed shows no prices and gives no investment advice.